Home > Insider Trading > Filing (0001209191-22-019277)

Filing Details

Accession Number:: 0001209191-22-019277
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-16 17:04:09
Reporting Period:: 2022-03-15

Accepted Time:: 2022-03-16 17:04:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891024	Patterson Companies Inc.	PDCO	Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)	410886515

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1341608	Donald Zurbay	1031 Mendota Heights St. Paul MN 55120	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-03-15	10,000	$30.88	94,755	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,061	Indirect	By ESOP

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Employee Stock Options	$30.77		2031-07-01	37,831	37,831	Direct
Common Stock	Employee Stock Options	$23.57		2030-07-14	57,819	57,819	Direct
Common Stock	Employee Stock Options	$22.25		2029-07-01	78,829	78,829	Direct
Common Stock	Employee Stock Options	$22.48	2021-07-01	2028-07-01	33,363	33,363	Direct
Common Stock	Employee Stock Options	$22.67		2028-06-29	99,250	99,250	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2031-07-01	37,831	37,831	Direct
2030-07-14	57,819	57,819	Direct
2029-07-01	78,829	78,829	Direct
2028-07-01	33,363	33,363	Direct
2028-06-29	99,250	99,250	Direct

Footnotes

The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on December 17, 2021.
Includes an aggregate of 37,134 RSUs awarded on 7/1/2018, 7/1/2019, 7/14/2020 and 7/1/2021 to Reporting Person pursuant to the Plan. The RSUs vest contingent upon continued employment as follows: 17,272 units vest 7/1/2022, 5,475 units vest 7/1/2023, 11,137 units vest 7/14/2023 and 3,250 units vest 7/1/2024.
Includes 33,625 RSU equivalents attributable to the July 1, 2020 determination by the Compensation Committee that the performance criteria for the period of April 27, 2019 through April 25, 2020 applicable to non-derivative performance units issued on July 1, 2019 had been satisfied. Subject to continued employment of the Reporting Person through July 1, 2022, the RSU equivalents will automatically convert into shares of common stock.
Represents shares of common stock indirectly held by the Reporting Person's Employee Stock Ownership Plan ("ESOP") account through May 21, 2021.
Stock options granted pursuant to the Plan on 7/1/2021.
Options are exercisable as follows: 33.3% on 7/1/2022, 33.3% on 7/1/2023 and 33.4% on 7/1/2024.
Stock options granted pursuant to the Plan on 7/14/2020.
Options are exercisable as follows: 33.3% on 7/14/2021, 33.3% on 7/14/2022 and 33.4% on 7/14/2023.
Stock options granted pursuant to the Plan on 7/1/2019.
Options are exercisable as follows: 33.3% on 7/1/2020, 33.3% on 7/1/2021 and 33.4% on 7/1/2022.
Stock options granted pursuant to the Plan on 7/1/2018.
Stock options granted as an inducement award granted outside the Plan on 6/29/2018. The stock options granted would vest pro-rata over the course of 3 years, with one-third of the shares vesting on 6/29/2019, one-third vesting on 6/29/2020, and the remaining one-third vesting 6/29/2021, in all cases subject to continued employments.